Effect of Curcumin-Piperine in moderate-to-high hepatic steatosis

Not Applicable

• Conditions: on-alcoholic fatty liver disease (NAFLD).; Abnormal results of liver function studies; R94.5

• Registration Number: IRCT20121216011763N47
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Willingness to participation in the study
Age 18-65 years
Evidence indicating non alcoholic fatty liver disease (NAFLD) white grade 2 and 3 diagnosed with sonography.

Exclusion Criteria

Alcohol use
People with heart , pulmonary and kidney diseases, hepatitis, cirrhosis, biliary and immune disorders, hypertension, diabetes, hypothyroidism and Cushing's syndrome
Consumption of Metformin, Vitamin E, Orsodeoxycholic acid, Phenytoin, tamoxifen, Lithium, Corticosteroids and Methotrexate within three months of the study.
Weight loss or bariatric surgery in recent years
Pregnancy
Supplement intolerance and unexpected adverse effects

Study & Design

• Study Type: interventional
• Study Design: Not specified